Cost-effectiveness of preoperative sestamibi scan for primary hyperparathyroidism is dependent solely upon the surgeon's choice of operative procedure

Journal of the American College of Surgeons

Volumn 186, Issue 3, 1998, Pages 293-305

  Denham, Daphne W ^a   Norman, James ^a,b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; HOSPITAL COST; HUMAN; IMAGE SUBTRACTION; LOCAL ANESTHESIA; MAJOR CLINICAL STUDY; META ANALYSIS; MULTICENTER STUDY; MULTIPLE CANCER; OPERATION DURATION; PARATHYROID SCINTISCANNING; PHYSICIAN ATTITUDE; PREOPERATIVE EVALUATION; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; TUMOR LOCALIZATION;

EID: 0031917185     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(98)00016-7     Document Type: Article

References (110)

1. Consensus Development Conference Panel. Diagnosis and management of asymptomatic primary hyperparathyroidism: Consensus Development Conference statement. Ann Intern Med 1994;114:593-597.
2. Doppman J. Reoperative parathyroid surgery: localization procedures, parathyroid surgery. Prog Surg 1986;18:117-136.
3. Kaplan E, Yashiro T, and Salti G. Primary hyperparathyroidism in the 1990s: choice of surgical procedures for this disease. Ann Surg 1992;215:300-317.
4. Auguste LJ, Attie JN, and Schnaap D. Initial failure of surgical exploration in patients with primary hyperparathyroidism. Am J Surg 1990:160:333-336.
5. Bruining HA, van Houten H, Juttman JR, et al. Results of operative treatment of 615 patients with primary hyperparathyroidism. World J Surg 1981;5:85.
6. Massachusetts General Hospital Series. In: Silverberg SG, ed. Surgical Pathology. Vol 2. New York: John Wiley and Sons; 1983:1445-1448.
7. Tibblin S, Bondeson AG, and Ljungberg O. Unilateral parathyroidectomy in hyperparathyroidism due to single adenoma. Ann Surg 1982:195:245-252.
8. Mitchell BK, Merrell RC, and Kinder BK. Localization studies in patients with hyperparathyroidism. Surg Clin North Am 1995; 75:483-498.
9. Miller DL. Pre-operative localization and interventional treatment of parathyroid tumors: when and how? World J Surg 1991; 15:706-715.
10. Broadie TA. Location, location, location. Am Surg 1997; 63:567-572.
11. Coakley AJ, Kettle AG, Wells CP, et al. 99Tcm sestamibi - a new agent for parathyroid imaging. Nucl Med Commun 1989; 10:791-794.
12. O'Doherty MJ, Kettle AG, Wells P, et al. Parathyroid imaging with technetium-99m-sestamibi: preoperative localization and tissue uptake studies. J Nucl Med 1992:33:313-318.
13. O'Doherty MJ. Radionuclide parathyroid imaging [Editorial]. J Nucl Med 1997:38:840-841.
14. Rossitch JC, Cowan RJ, Ellis MB, and Griffith RF. Tc-99m sestamibi for detection of parathyroid adenoma: comparison of single and dual tracer imaging. Clin Nucl Med 1995; 20:220-221.
15. Light VL, McHenry CR, Jarjoura D, et al. Prospective comparison of dual-phase technetium-99m-sestamibi scintigraphy and high resolution ultrasonography in the evaluation of abnormal parathyroid glands. Am Surg 1996;62:562-568.
16. McIntyre RC, Kumpe DA, and Liechty D. Reexploration and angiographie ablation for hyperparathyroidism. Arch Surg 1994; 129:499-505.
17. Rantis PC, Prinz RA, and Wagner RH. Neck radionuclide scanning: a pitfall in parathyroid localization. Am Surg 1995; 61:641-646.
18. Silver CE, and Velez FJ. Parathyroid re-exploration. Am J Surg 1992;164:606-609.
19. Borley NR, Collins REC, O'Doherty M, and Coakley A. Technetium-99m sestamibi parathyroid localization is accurate enough for scan-directed unilateral neck exploration. Br J Surg 1996;83:989-991.
20. Chapuis Y, Fulla Y, Bonnichon P, et al. Values of ultrasonography, sestamibi scintigraphy, and intraoperative measurement of 1-84 PTH for unilateral neck exploration of primary hyperparathyroidism. World J Surg 1996;20:835-840.
21. Irvin GL, Prudhomme DL, Deriso GT, et al. A new approach to parathyroidectomy. Ann Surg 1994;219:574-581.
22. Norman J, Chheda H, and Farrell C. Minimally invasive parathyroidectomy for primary hyperparathyroidism: decreasing operative time and potential complications while improving cosmetic results. Am Surg (in press).
23. Sofferman RA, Nathan MH, Fairbank JT, et al. Preoperative technetium Tc 99m sestamibi imaging: paving the way to minimal-access parathyroid surgery. Arch Otolaryngol Head Neck Surg 1996;122:369-374.
24. Takami H. Surgical management of hyperparathyroidism in view of a reliable parathyroid adenoma localization test. Surgery 1997:120:120.
25. Pyrtek LJ, Belkin M, Bartus S, and Schweizer R. Parathyroid gland exploration with local anesthesia in elderly and high-risk patients. Arch Surg 1988;123:614-617.
26. Ditkoff BA, Chabot J, Feind C, and Gerfo PL. Parathyroid surgery using monitored anesthesia care as an alternative to general anesthesia. Am J Surg 1996; 172:698-700.
27. Irvin GL, Sfakianakis G, Yeung L, et al. Ambulatory parathyroidectomy for primary hyperparathyroidism. Arch Surg 1996; 131:1074-1078.
28. Norman J, and Chheda H. Minimally invasive parathyroidectomy facilitated by intraoperative nuclear mapping. Surgery 1997:122:998-1004.
29. Harrison TS, Duarte B, Reitz RE, et al. Four- to eight-year post-operative follow-up demonstrating persistent functional insignificance of microscopic parathyroid hyperplasia and decreased autonomy of parathyroid hormone release. Ann Surg 1981; 194:429-437.
30. LiVolsi VA, and Hamilton R. Intraoperative assessment of parathyroid gland pathology: a common view from the surgeon and the pathologist. Am J Clin Pathol 1994;102:365-373.
31. Bonjer HJ, Bruining HA, Birkenhager JC, et al. Single and multigland disease in primary hyperparathyroidism: clinical follow-up, histopathology, and flow cytometric DNA analysis. World J Surg 1992:16:737-744.
32. Elkis H, Friedman L, Wise A, and Meltzer HY Meta-analyses of studies of ventricular enlargement and cortical sulcal prominence in mood disorder: comparisons with controls or patients with schizophrenia. Arch Gen Psychiatry 1995:52:735-746.
33. Achong DM, and Oates E. Tc-99m sestamibi uptake by parathyroid carcinoma: false-positive localization of parathyroid adenoma. J Nucl Med 1994:8:735.
34. Arkles LB, Jones T, Hicks RJ, et al. Impact of complementary parathyroid scintigraphy and ultrasonography on the surgical management of hyperparathyroidism. Surgery 1996;120:845-851.
35. Arbab AS, Koizumi K, Hemmi A, et al. Tc-99m-MIBI scintigraphy for detecting parathyroid adenoma and hyperplasia. Ann Nucl Med 1997:11:45-49.
36. Billotey C, Aurengo A, Najean Y, et al. Identifying abnormal parathyroid glands in the thyroid uptake area using technetium-99m-sestamibi and factor analysis of dynamic structures. J Nucl Med 1994:35:1631-1636.
37. Billotey C, Sarfati E, Aurengo A, et al. Advantages of SPECT in technetium-99m-sestamibi parathyroid scintigraphy. J Nucl Med 1996:37:1773-1778.
38. Bonjer HJ, Bruining HA, Pols HAP, et al. Intraoperative nuclear guidance in benign hyperparathyroidism and parathyroid cancer. Eur J Nucl Med 1997:24:246-251.
39. Bugis SP, Berno E, Rusnak CH, and Chu D. Technetium99m sestamibi scanning before initial neck exploration in patients with primary hyperparathyroidism. Eur Arch Otorhinolaryngol 1995;252:149-152.
40. Caixas A, Berna L, Piera J, et al. Utility of 99mTc-sestamibi scintigraphy as a first-line imaging procedure in the preoperative evaluation of hyperparathyroidism. Clin Endocrinol (Oxf) 1995:43:525-530.
41. Caravalho J, Balingit AG, Rivera-Rodriguex JE, et al. Localization of an ectopic parathyroid adenoma by double-phase technetium-99m-sestamibi scintigraphy. J Nucl Med 1995; 36:1840-1842.
42. Chen CC, Premkumar A, Hill SC, et al. Tc-99m sestamibi imaging of a hyperfunctioning parathyroid autograft with Doppler ultrasound and MRI correlation. Clin Nucl Med 1995; 20:222-225.
43. Chen EM, and Mishkin FS. Parathyroid hyperplasia may be missed by double-phase Tc-99m sestamibi scintigraphy alone. Clin Nucl Med 1997:22:222-226.
44. Chiu NT, Cheng HM, and Yao WJ. Tc-99m sestamibi scanning in the preoperative localization of mediastinal parathyroid adenomas. Ann Nucl Med 1995:9:157-159.
45. Doppman JL, Skarulis MC, Chen CC, et al. Parathyroid adenomas in the aortopulmonary window. Radiology 1996; 201:456-462.
46. Freitas JE, and Freitas AE. Thyroid and parathyroid imaging. Semin Nucl Med 1994;24:234-245.
47. Heller KS, and Attie JN. Parathyroid localization: inability to predict multiple gland involvement. Am J Surg 1993; 166:357-359.
48. Ishibashi M, Nishida H, Kumabe T, et al. Tc-99m tetrofosmin: a new diagnostic tracer for parathyroid imaging. Clin Nucl Med 1995:20:902-905.
49. Johnston LB, Carroll MJ, Britton KE, et al. The accuracy of parathyroid gland localization in primary hyperparathyroidism using sestamibi radionuclide imaging. J Clin Endocrinol Metab 1996;81:346-352.
50. Lee VS, Wilkinson RH, Leight GS, et al. Hyperparathyroid in high-risk surgical patients: evaluation with double-phase technetium-99m sestamibi imaging. Radiology 1995:197: 627-633.
51. Leslie WD, Riese KT, Dupont JO, and Peterdy AE. Parathyroid adenomas without sestamibi retention. Clin Nucl Med 1995:20:699-702.
52. Martin D, Rosen IB, and Ichise M. Evaluation of single isotope technetium 99m sestamibi in localization efficiency for hyperparathyroidism. Am J Surg 1996:172:633-636.
53. Martinez DA, King DR, Romshe C, et al. Intraoperative identification of parathyroid gland pathology: a new approach. J Pediatr Surg 1995:30:1306-1309.
54. McBiles M, Lambert AT, Cote MG, and Kim SY. Sestamibi parathyroid imaging. Semin Nucl Med 1995;XXV:221-234.
55. McHenry CR, Lee K, Saadey J, et al. Parathyroid localization with technetium-99m-sestamibi: a prospective evaluation. J Am Coll Surg 1996:183:25-30.
56. Mitchell BK, Cornelius EA, Zoghbi S, et al. Mechanism of technetium 99m sestamibi parathyroid imaging and the possible role of p-glycoprotein. Surgery 1996;120:1039-1045.
57. Neumann DR, Esselstyn CB, Kim EY, et al. Preliminary experience with double-phase SPECT using Tc-99m sestamibi in patients with hyperparathyroidism. Clin Nucl Med 1997; 22:217-221.
58. Neumann DR, Esselstyn CB, MacIntyre WJ, et al. Comparison of FDG-PET and sestamibi-SPECT in primary hyperparathyroidism. J Nucl Med 1996:37:1809-1815.
59. Peeler BB, Martin WH, Sandler MP, and Goldstein RE. Sestamibi parathyroid scanning and preoperative localization studies for patients with recurrent/persistent hyperparathyroidism or significant comorbid conditions: development of an optimal localization strategy. Am Surg 1997;63:37-46.
60. Rodriquez JM, Tezelman S, Siperstein AE, et al. Localization procedures in patients with persistent or recurrent hyperparathyroidism. Arch Surg 1994;129:870-875.
61. Sarfati E, Billotey C, Halimi B, et al. Early localization and reoperation for persistent primary hyperparathyroidism. Br J Surg 1997;84:98-100.
62. Sfakianakis GN, Irvin GL, Mallin W, et al. Efficient parathyroidectomy guided by SPECT-MIBI and hormonal measurements. J Nucl Med 1996;37:798-804.
63. Sinha CK, Hamaker R, Hamaker RC, et al. Utility of preoperative radionuclide scanning for primary hyperparathyroidism. Laryngoscope 1997;107:753-758.
64. Staudenherz A, Telfeyan D, Steiner E, et al. Scintigraphic pitfalls in giant parathyroid glands. J Nucl Med 1995;36:467-469.
65. Sutter CW, and Shelton DK. Four ectopic parathyroid glands detected with Tc-99m sestamibi. Clin Nucl Med 1997; 22:120-121.
66. Vojvodich SM, and Lampe HB. Imaging and surgery in hyperparathyroidism: a 10-year review. J Otolaryngol 1996;25:126-129.
67. Waters GS, Burke GJ, Corley JH, and Wei JP. In vivo uptake of technetium-99m-sestamibi by parathyroid glands in comparison to surrounding tissues of the neck. Am Surg 1997;63:195-198.
68. Weber CJ, Vansant J, Alazraki N, et al. Value of technetium 99m sestamibi iodine 123 imaging in reoperative parathyroid surgery. Surgery 1993;114:1011-1018.
69. Bergenfelz A, Tennvall J, Valdermarsson S, et al. Sestamibi versus thallium subtraction scintigraphy in parathyroid localization: a prospective comparative study in patients with predominantly mild primary hyperparathyroidism. Surgery 1997;121:601-605.
70. Caixas A, Berna L, Hernandez A, et al. Efficacy of preoperative diagnostic imaging localization of technetium 99m-sestamibi scintigraphy in hyperparathyroidism. Surgery 1997;121:535-541.
71. Carter WB, Sarfati MR, Fox KA, and Patton DD. Preoperative detection of sporadic parathyroid adenomas using technetium-99m-sestamibi: what role in clinical practice? Am Surg 1997;63: 317-321.
72. Casas AT, Burke GJ, Sathyanarayana, et al. Prospective comparison of technetium-99m-sestamibi/iodine-123 radionuclide scan versus high-resolution ultrasonography for the preoperative localization of abnormal parathyroid glands in patients with previously unoperated primary hyperparathyroidism. Am J Surg 1993;166:369-373.
73. Chen CC, Holder LE, Scovill WA, et al. Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT. J Nucl Med 1997;38: 834-839.
74. Fjeld JG, Pfeffer PF, Clausen OPF, and Rootwelt K. Technetium-99m-tetrofosmin for parathyroid scintigraphy: a comparison with sestamibi. J Nucl Med 1997;38:831-834.
75. Hindie E, Melliere D, Perlemuter L, et al. Primary hyperparathyroidism: higher success rate of first surgery after preoperative Tc-99m sestamibi-I-123 subtraction scanning. Radiology 1997; 204:221-228.
76. Khan A, Samtani S, Varma VM, et al. Preoperative parathyroid localization: prospective evaluation of technetium 99m sestamibi. Otolaryngol Head Neck Surg 1994;111:467-472.
77. Malhotra A, Silver CE, Deshpande V, and Freeman LM. Preoperative parathyroid localization with sestamibi. Am J Surg 1996; 172:637-640.
78. Perez-Monte JE, Brown ML, Shah AN, et al. Parathyroid adenomas: accurate detection and localization with Tc-99m sestamibi SPECT. Radiology 1996;201:85-91.
79. Shaha AR, Sarkar S, Strashun A, and Yeh S. Sestamibi scan for preoperative localization in primary hyperparathyroidism. Head Neck 1997;19:87-91.
80. Taillefer R, Boucher Y, Potvin C, and Lamber R. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study). J Nucl Med 1992;33:1801-1807.
81. Thompson GB, Mullan BP, Grant CL, et al. Parathyroid imaging with technetium-99m-sestamibi: an initial institutional experience. Surgery 1994;116:966-973.
82. Thule P, Thakore K, Vansant J, et al. Preoperative localization of parathyroid tissue with technetium-99m sestamibi 123I subtraction scanning. J Clin Endocrinol Metab 1993;78:77-82.
83. Wei JP, Burke GJ, and Mansberger AR. Prospective evaluation of the efficacy of technetium 99m sestamibi and iodine 123 radionuclide imaging of abnormal parathyroid glands. Surgery 1992; 112:1111-1117.
84. Wei JP, Burke GJ, and Mansberger AR. Preoperative imaging of abnormal parathyroid glands in patients with hyperparathyroid disease using combination Tc-99m-pertechnetate and Tc-99m-sestabmibi radionuclide scans. Ann Surg 1994;219: 568-573.
85. Casas AT, Burke GJ, Mansberger AR, and Wei JP. Impact of technetium-99m-sestamibi localization on operative time and success of operations for primary hyperparathyroidism. Am Surg 1994;60:12-17.
86. Halvorson DJ, Burke GJ, Mansberger AR, and Wei JP. Use of technetium Tc 99m sestamibi and iodine 123 radionuclide scan for preoperative localization of abnormal parathyroid glands in primary hyperparathyroidism. South Med J 1994;87:336-339.
87. Hindie E, Melliere D, Simon D, et al. Primary hyperparathyroidism: is technetium-sestamibi/iodine-123 subtraction scanning the best procedure to locate enlarged glands before surgery? J Clin Endocrinol Metab 1995;80:302-307.
88. Shen W, Sabanci U, Morita ET, et al. Sestamibi scanning is inadequate for directing unilateral neck exploration for first-time parathyroidectomy. Arch Surg 1997;132:969-976.
89. Bergenfelz A, Algotsson L, and Ahren B. Surgery for primary hyperparathyroidism performed under local anesthesia. Br J Surg 1992;79:931-934.
90. Kairaluoma MI, Makarainen H, Salo-Zetterman E, et al. Cost effectiveness of ultrasound in primary parathyroid surgery. Br J Surg 1989;76:596-597.
91. Lucas RJ, Welsh RJ, and Glover JL. Unilateral neck exploration for primary hyperparathyroidism. Arch Surg 1990;125:962-965.
92. Lundgren EC, Gillott AR, Wisman JS, and Beck J. The role of preoperative localization in primary hyperparathyroidism. Am Surg 1995;61:393-396.
93. Roe SM, Burns RP, Graham LD, et al. Cost-effectiveness of preoperative localization studies in primary hyperparathyroid disease. Ann Surg 1994;219:582-586.
94. Ryan JA, Eisenberg B, Pado KM, and Lee F. Efficacy of selective unilateral exploration in hyperparathyroidism based on localization tests. Arch Surg 1997;132:886-891.
95. Serpell JW, Campbell PR, and Young AE. Preoperative localization of parathyroid tumors does not reduce operating time. Br J Surg 1991;78:589-590.
96. Summers GW, Dodge DL, and Kammer H. Accuracy and costeffectiveness of preoperative isotope and ultrasound imaging in primary hyperparathyroidism. Otolaryngol Head Neck Surg 1989;100:210-217.
97. Wei JP, and Burke GJ. Analysis of savings in operative time for primary hyperparathyroidism using localization with technetium 99m sestamibi scan. Am J Surg 1995;170:488-491.
98. Worsey MJ, Carty SE, and Watson CG. Success of unilateral neck exploration for sporadic primary hyperparathyroidism. Surgery 1993;114:1024-1030.
99. Billy HT, Rimkus DR, Hartzman S, and Latimer RG. Technetium-99m-sestamibi single agent localization versus high resolution ultrasonography for the preoperative localization of parathyroid glands in patients with primary hyperparathyroidism. Am Surg 1995;61:882-888.
100. Doherty GM, Weber B, and Norton JA. Cost of unsuccessful surgery for primary hyperparathyroidism. Surgery 1994; 116: 954-958.
101. Lucas RJ, Welsh RJ, and Glover JL. Unilateral neck exploration for primary hyperparathyroidism. Arch Surg 1990;125:962-965.
102. Ballard JL, Deiparine MK, Bergan JJ, et al. Cost-effective evaluation and treatment for carotid disease. Arch Surg 1997; 132: 268-271.
103. Weigelt JA. Invited commentary. Arch Surg 1997;132:925.
104. Paloyan E, Lawrence AM, Baker WH, et al. Near total parathyroidectomy. Surg Clin North Am 1969;49:43-48.
105. Haff RC, and Ballinger WF. Causes of recurrent hypercalcemia after parathyroidectomy for primary hyperparathyroidism. Ann Surg 1971; 173:884-891.
106. Proye CA, Carnaille B, Bizard JP, et al. Multiglandular disease in seemingly sporadic primary hyperparathyroidism revisited: where are we in the early 1990s? A plea against unilateral parathyroid exploration. Surgery 1992;112:1118-1122.
107. Duh QY, Uden P, and Clark OH. Unilateral neck exploration for primary hyperparathyroidism: analysis of a controversy using a mathematical model. World J Surg 1992;16:654-662.
108. Sofferman RA, Nathan MH, Fairbank JT, et al. Preoperative technetium Tc 99m sestamibi imaging: paving the way to minimal-access parathyroid surgery. Arch Otolaryngol Head Neck Surg 1996;122:369-374.
109. Robertson GS, Johnson PR, Bolia A, et al. Long-term results of unilateral neck exploration for preoperatively localized nonfamilial parathyroid adenomas. Am J Surg 1996; 172: 311-314.
110. Tibblin S, BizardJP, Bondeson AG, et al. Primary hyperparathyroidism due to solitary adenoma: a comparative multicentre study of early and long term results of different surgical regimens. Eur J Surg 1991;157:511-515